Evidence map›Paper›PMID 40092892›Full record

ArticleBioinformation2024

Effect of oral alpha lipoic acid in treatment of OSMF.

Shafeem Khan Ak, Vikas Kulkarni, Abhay D Havle

Abstract read
In one paragraph

Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shafeem Khan AkDepartment of ENT, Krishna Institute of Medical Sciences, Karad - 415110, Maharashtra, India.
Vikas KulkarniDepartment of ENT, Krishna Institute of Medical Sciences, Karad - 415110, Maharashtra, India.
Abhay D HavleDepartment of Otorhinolaryngology, Krishna Institute of Medical Sciences, Karad - 415 539, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral submucous fibrosis (OSMF) is a potentially cancerous disorder that affects the oral mucosa and causes a range of symptoms. Therefore it is of interest to assessing the function of oral alpha lipoic acid as a therapy for OSMF is intriguing. Hence, fifty patients with OSMF symptoms were evaluated both before and after treatment. They were split into two groups: group A, which served as the control, received 1 ml steroid injection of thioacetamide and 1500 IU of hyaluronidase (HYAL) weekly along with the oral antioxidant α-lipoic acid for three months. Group B, which served as the case study, also received 3 months of steroid injection of thioacetamide and HYAL. Patients in group B were recalled for a clinical examination using a vernier caliper, and visual analog scale (VAS) and fibrous bands (FB) were assessed at the 1

Indexed as

Alpha lipoic acidhyaluronidaseoral submucous fibrosisthioacetamidevernier caliper

Identifiers

PMID40092892
PMCPMC11904147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.